未登录

余

余丽芳 (Li-Fang Yu)

hangzhou geriatric hospital

H指数:27

被引数:1,875

个人简介

"教育经历 2009.09 - 2013.06 美国伊利诺伊大学芝加哥分析，博士后，合作导师：Alan P. Kozikowski教授 2004.09 - 2009.06 中国科学院上海药物研究所，博士，导师：南发俊研究员 2000.09 - 2004.06 北京师范大学，学士工作经历 2018.12 - 至今华东师范大学，研究员 2018.10 - 至今华东师范大学，紫江青年研究员(破格) 2013.07 - 2018.12 华东师范大学，副研究员荣誉及奖励 2018年中国药学会-施维雅青年药物化学奖 2018年至今华东师范大学紫江青年研究员"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Does pneumonia increase the risk of dementia and cognitive decline? A systematic review and meta-analysis

肺炎会增加痴呆和认知功能下降的风险吗？一项系统评价和荟萃分析

Annals of Medicine

IF4.3

2025-06-230

OA

Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition

基于结构的3,4-稠合三环苯并呋喃衍生物的研制：作为聚酮合酶13抑制剂的开发，具有可忽略的hERG抑制活性

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-03-060

PRE

Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis (vol 283, 117148, 2025)

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-03-010

PRE

Design, synthesis, and biological evaluations of 5-aryl-pyrazole-3-carboxamide derivatives as selective CB2 receptor agonists for the treatment of colitis

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-02-010

PRE

Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis

基于结构的N-芳基吲哚衍生物作为结核分枝杆菌Pks13抑制剂的开发

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-02-011

PRE

Design, synthesis, and biological evaluation of 1,2,4-triazole derivatives as potent antitubercular agents

CHINESE CHEMICAL LETTERS

IF8.9

2024-03-017

PRE

Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-07-013

OAAI

Synthesis and Biological Evaluation of 3-Amino-4,4-Dimethyl Lithocholic Acid Derivatives as Novel, Selective, and Cellularly Active Allosteric SHP1 Activators

IF4.6

2023-03-081

OAAI

Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-09-2912

PRE

Predicting the molecular subtypes of breast cancer using nomograms based on three-dimensional ultrasonography characteristics

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-191

OAAI

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis

IF4.6

2022-04-299

OAAI

Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1)

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-01-2814

PRE

Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-01-0115

PRE

Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2021-09-274

PREAI

Therapeutic Potential of Coumestan Pks13 Inhibitors for Tuberculosis

Coumestan Pks13抑制剂对结核病的治疗潜力

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2021-04-1919

OA

Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-03-0125

OAAI

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia

IF4.6

2021-02-245

OAAI

Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells

RSC MEDICINAL CHEMISTRY

IF3.6

2021-01-015

OA

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

BIOSENSORS & BIOELECTRONICS

IF10.5

2021-01-0134

PREAI

From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-12-3113

PREAI